These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 18083007)

  • 1. A large-scale validation study of the Medication Adherence Rating Scale (MARS).
    Fialko L; Garety PA; Kuipers E; Dunn G; Bebbington PE; Fowler D; Freeman D
    Schizophr Res; 2008 Mar; 100(1-3):53-9. PubMed ID: 18083007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability and validity of the Medication Adherence Rating Scale in a cohort of patients with schizophrenia from Nigeria.
    Owie GO; Olotu SO; James BO
    Trends Psychiatry Psychother; 2018; 40(2):85-92. PubMed ID: 29768528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
    Byerly MJ; Nakonezny PA; Rush AJ
    Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Four measures of treatment compliance among patients recovering from psychotic episodes--a comparative study].
    Friemann K; Wciórka J
    Psychiatr Pol; 2013; 47(5):759-73. PubMed ID: 25011225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset.
    Fond G; Boyer L; Boucekine M; Aden LA; Schürhoff F; Tessier A; Andrianarisoa M; Berna F; Brunel L; Capdevielle D; Chereau I; Mallet J; Denizot H; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Rey R; Richieri R; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Misdrahi D;
    Schizophr Res; 2017 Apr; 182():84-89. PubMed ID: 27789187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.
    Kao YC; Liu YP
    Compr Psychiatry; 2010; 51(6):557-65. PubMed ID: 20965300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses.
    Thompson K; Kulkarni J; Sergejew AA
    Schizophr Res; 2000 May; 42(3):241-7. PubMed ID: 10785582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric evaluation of medication adherence rating scale (MARS) among Nigerian patients with schizophrenia.
    Sowunmi OA; Onifade PO
    Niger J Clin Pract; 2019 Sep; 22(9):1281-1285. PubMed ID: 31489867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the Italian version of the subjective well-being under neuroleptic (SWN) scale in schizophrenic outpatients.
    Balestrieri M; Giaroli G; Mazzi M; Bellantuono C
    Pharmacopsychiatry; 2006 May; 39(3):81-4. PubMed ID: 16721695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity and reliability of a self-reported measure of medication adherence in patients with Type 2 diabetes mellitus in Singapore.
    Wang Y; Lee J; Toh MP; Tang WE; Ko Y
    Diabet Med; 2012 Sep; 29(9):e338-44. PubMed ID: 22672497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients.
    Vernon MK; Revicki DA; Awad AG; Dirani R; Panish J; Canuso CM; Grinspan A; Mannix S; Kalali AH
    Schizophr Res; 2010 May; 118(1-3):271-8. PubMed ID: 20172695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insight: demographic differences and associations with one-year outcome in schizophrenia and schizoaffective disorder.
    Wiffen BD; Rabinowitz J; Fleischhacker WW; David AS
    Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):169-75. PubMed ID: 20880827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 4-Point ordinal Alliance Self-report: a self-report questionnaire for assessing therapeutic relationships in routine mental health.
    Misdrahi D; Verdoux H; Lançon C; Bayle F
    Compr Psychiatry; 2009; 50(2):181-5. PubMed ID: 19216896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative impact of self-stigmatization on attitude toward medication adherence in patients with psychosis.
    Uhlmann C; Kaehler J; Harris MS; Unser J; Arolt V; Lencer R
    J Psychiatr Pract; 2014 Sep; 20(5):405-10. PubMed ID: 25226204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
    Yang J; Ko YH; Paik JW; Lee MS; Han C; Joe SH; Jung IK; Jung HG; Kim SH
    Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence styles of schizophrenia patients identified by a latent class analysis of the Medication Adherence Rating Scale (MARS): a six-month follow-up study.
    Jaeger S; Pfiffner C; Weiser P; Kilian R; Becker T; Längle G; Eschweiler GW; Croissant D; Schepp W; Steinert T
    Psychiatry Res; 2012 Dec; 200(2-3):83-8. PubMed ID: 22534500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.